BOSTON – Emulate, Inc., announced the official opening of its new headquarters and laboratories in Boston’s Seaport District, at 27 Drydock Avenue within The Innovation and Design Building. The new facility will be a workplace for the company’s 40 employees, with plans for expansion to 85 employees within the coming year. Coming just 18 months […]
SANTA CLARA, Calif., – Agilent Technologies Inc. (NYSE: A) announced a program that gives biologists conducting functional genomics research early access to a potential new resource: custom CRISPR guideRNA libraries using Agilent’s high-quality oligo library synthesis platform. Agilent announced the early access program at a technology conference—Advances in Genome Biology and Technology (AGBT)—which continues through […]
Hilden, Germany, and Germantown, Maryland, February 11, 2016 – QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) announced the introduction of more than 170 new QIAseq Targeted RNA Panels for gene expression profiling, expanding QIAGEN’s portfolio of Sample to Insight solutions for next-generation sequencing (NGS). The panels enable researchers to select from over 20,000 human […]
ORLANDO, Fla., — Silicon Biosystems Menarini Inc., a developer and manufacturer of technologies and products that help uncover the biological complexities of disease at the single-cell level, and Swift Biosciences Inc., a developer of innovative technologies for genomics research, announced a scientific collaboration and co-marketing partnership aimed at enabling translational researchers to obtain high-quality sequencing […]
AMSBIO announces an extensive collection of recombinant Fc receptor proteins, including their common variants, to help accelerate the development of therapeutic monoclonal antibodies (mAb). Therapeutic antibody efficacy depends not only on the Fab fragment and its binding activity to the target antigen, but also depends on the Fc fragment and its interaction with key Fc […]
Göteborg, Sweden, and Shanghai, China, February 9, 2016 – TATAA Biocenter, the world´s foremost organizer of hands-on training in molecular diagnostics and Europe´s leading provider of genomic services, has partnered with Yikon Genomics to advance its Next Generation Sequencing (NGS) and single cell profiling offerings. As part of the partnership, TATAA Biocenter will distribute and […]
SAN FRANCISCO, Calif. — Twist Bioscience, a company accelerating science and innovation through rapid, high-quality DNA synthesis founded by Bill Banyai, Ph.D., Emily Leproust, Ph.D. and Bill Peck, Ph.D. approximately three years ago, today issued the following statement: On February 3, 2016, Agilent Technologies filed a complaint against Twist Bioscience and one of its founders, […]
Hudson, NY – Taconic Biosciences, a leading provider of genetically modified mouse models and associated services to researchers worldwide, announced it has launched the huNOG-EXL, an extended lineage mouse model that will greatly improve immuno-oncology, allergy and inflammation research. Available exclusively from Taconic, the huNOG-EXL incorporates an engrafted human immune system to recapitulate myeloid lineages […]
LIMERICK, PA – Rockland Immunochemicals, Inc. (Rockland) announces the availability of a new collection of human melanoma cell lines that have been developed and characterized over several decades in the laboratory of Meenhard Herlyn, D.V.M., D.Sc., Caspar Wistar Professor in Melanoma Research, Director of the Melanoma Research Center, and professor in the Molecular and Cellular […]
Fremont, CA –– DiscoverX Corporation, a leading supplier of innovative cell-based assays and services for drug discovery and development, today announced the launch of the KILR Cytotoxicity Assay, a pioneering approach to accelerate the development of cancer immunotherapy drugs. Development of complex cancer immunotherapy drugs requires robust cell-based assays that allow scientists to determine whether […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
